Upexi, Inc.
NASDAQ:UPXIInternet Content & Information
-$0.04 today
- Market cap
- $51.54M
- Beta
- -0.33
- P/E (TTM)
- -0.3
- EPS (TTM)
- -$3.49
Volume 0.93M
Average 3.19M
UPXI Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Upexi, Inc.NASDAQ: UPXI
Accounts Receivables · Q3 FY2026 · quarter ended Mar 2026
Accounts receivables declines year over year
Q3 FY2026 accounts receivables of $98.16K fell 77.0% year over year, ahead of the -892.8% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at +203.6% a year.
Context
- Accounts receivables amounted to 3.1% of revenue in FY2025, up 0.5 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -77.0% holds above the trailing-twelve-month pace of -892.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (484.58K) USD
- Year-over-year change
- -171.7%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | (484.58K) | -171.7% |
| FY2024 | 2024-06-30 | 675.71K | +285.3% |
| FY2023 | 2023-06-30 | (364.67K) | -2006.4% |
| FY2022 | 2022-06-30 | (17.31K) | +98.5% |
| FY2021 | 2021-06-30 | (1.14M) | — |
Accounts Receivables vs competitors
How UPXI compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -892.8% is the lowest of 9, against a peer median of +84.2%.
- Accounts receivables amounts to 2.7% of revenue for UPXI, versus a peer median of 2.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $48.42M USD | +62.3% | +39.3% | 8.8% | |
| LTM Mar 2026 | €22.2M EUR | +106.2% | +25.2% | 3.9% | |
| LTM Mar 2026 | $12.77M USD | +739.3% | — | 10.3% | |
| LTM Mar 2026 | $9.51M USD | -120.7% | -40.8% | 0.4% | |
| LTM Mar 2026 | $6.21M USD | -168.1% | -51.4% | 0.8% | |
| LTM Mar 2026 | $3.43M USD | +272.9% | +21.2% | 4.7% | |
| LTM Mar 2026 | $1.91M USD | +167.2% | — | 2.7% | |
| LTM Mar 2026 | $1.03M USD | -100.7% | +114.4% | 0.1% | |
| LTM Mar 2026 | $695.19K USD | -892.8% | +203.6% | 2.7% | |
| LTM Dec 2025 | $0 USD | — | — | 0.0% | |
| Peer median (excluding UPXI) | — | +84.2% | +23.2% | 2.7% | |
Competitors are the stored peer set for UPXI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | 2.98M | (2.1M) | (16.93M) | (25.27M) | (13.68M) |
| Depreciation & Amortization | 1.03M | 2.73M | 3.54M | 3.68M | 757.76K |
| Deferred Income Tax | (1.28M) | (1.06M) | 0 | (344.8K) | 0 |
| Stock-Based Compensation | 611.43K | 3.33M | 3.66M | 0 | 2.11M |
| Change in Working Capital | (521.93K) | (3.31M) | (1.44M) | 2.89M | 1.93M |
| Accounts Receivables | (1.14M) | (17.31K) | (364.67K) | 675.71K | (484.58K) |
| Inventory | (846.66K) | (2.45M) | (1.37M) | 2.65M | (470.19K) |
| Accounts Payables | 1.97M | (430.51K) | 389.46K | (944.02K) | 2.87M |
| Other Working Capital | (503.85K) | (411.33K) | 292.04K | 509.97K | 20.87K |
| Other Non-Cash Items | 123.65K | 924.9K | 11.36M | 18.94M | 465.19K |
| Operating Cash Flow | 2.94M | 521.87K | 202.68K | (101.38K) | (8.42M) |
| Capital Expenditures | (1.42M) | (6.15M) | (937.56K) | (932.56K) | (387.76K) |
| Acquisitions (Net) | 62.12K | (5.46M) | (4.58M) | 1.56M | 6.01M |
| Purchases of Investments | 0 | (1.03M) | 0 | 0 | (104.91M) |
| Sales of Investments | 0 | 1.03M | 0 | 0 | 0 |
| Other Investing Activities | 79K | 6K | 2.94M | (4M) | 0 |
| Investing Cash Flow | (1.28M) | (11.61M) | (2.57M) | (3.38M) | (99.29M) |
| Debt Repayment | 988.08K | 5.68M | (1.56M) | (353.79K) | 16.9M |
| Common Stock Issued | 10.95M | 0 | 0 | 0 | 93.13M |
| Common Stock Repurchased | 0 | (1.98M) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 1.28M | 0 | 0 |
| Financing Cash Flow | 11.99M | 3.7M | (285.33K) | (353.79K) | 110.03M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 13.65M | (7.38M) | (2.66M) | (3.83M) | 2.31M |
| Free Cash Flow | 1.52M | (5.63M) | (734.89K) | (1.03M) | (8.81M) |
Upexi, Inc.
NASDAQ:UPXI
Intrinsic Alpha fair value
Locked
Current Price
$0.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.